js004
mAbexperimental
Clinical trial activity
19 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
14
Phase 3
2
Phase 4
0
Earliest trial started Mar 31, 2020 (NCT04278859)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Renal Cell · Phase 2
- Carcinoma, Transitional Cell · Phase 1
- Colorectal Neoplasms · Phase 1
- Esophageal Squamous Cell Carcinoma · Phase 2
- Hodgkin Disease · Phase 3
- Kidney Neoplasms · Phase 2
- Lung Neoplasms · Phase 3
- Lymphoma · Phase 1
- Melanoma · Phase 1
- Nasopharyngeal Carcinoma · Phase 1/Phase 2
- Neoplasms · Phase 1
- Pancreatic Neoplasms · Phase 1/Phase 2
- Small Cell Lung Carcinoma · Phase 2
- Squamous Cell Carcinoma of Head and Neck · Phase 1/Phase 2
Mechanism of action
- BTLAINHIBITOR
BTLA inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07101614 | Phase 2 | Sep 1, 2025 | Shengjing Hospital |
| NCT06924606 | Phase 2 | Jul 15, 2025 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT06732258 | Phase 1 | Jan 10, 2025 | Sichuan University |
| NCT06730932 | Phase 2 | Dec 30, 2024 | Jiao Tong University |
| NCT06648200 | Phase 2 | Nov 1, 2024 | Huazhong University of Science and Technology |
| NCT06588335 | Phase 2 | Sep 30, 2024 | Henan Provincal People's Hospital |
| NCT06690697 | Phase 2 | Jun 1, 2024 | Fudan University |
| NCT06370754 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2024 | Fudan University |
| NCT06256237 | Phase 2 | Apr 1, 2024 | Huazhong University of Science and Technology |
| NCT06170489 | Phase 3 | Dec 22, 2023 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT06095583 | Phase 3 | Oct 25, 2023 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT05891080 | Phase 2 | Jul 1, 2023 | Huazhong University of Science and Technology |
| NCT05664971 | Phase 1/Phase 2 (Phase 2) | Dec 23, 2022 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT05427396 | Phase 1 | Aug 9, 2022 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT05000684 | Phase 1/Phase 2 (Phase 2) | Aug 27, 2021 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT04929080 | Phase 1/Phase 2 (Phase 2) | May 12, 2021 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT04773951 | Phase 1 | Apr 12, 2021 | Chinese Academy of Medical Sciences, Shanghai Junshi Bioscience Co.,Ltd. |
| NCT04477772 | Phase 1 | Jul 24, 2020 | Shanghai Junshi Bioscience Co.,Ltd. |
| NCT04278859 | Phase 1 | Mar 31, 2020 | Shanghai Junshi Bioscience Co.,Ltd. |
Showing 19 of 19 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 10 | 10 | 3 | 2020 |
| Huazhong University of Science and Technology | Academic/Hospital | 3 | 3 | 1 | 2023 |
| Fudan University | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Henan Provincal People's Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Shengjing Hospital | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2022 |
9 organizations
Page 1 / 1